(Q38874230)

7 September 2017

NECT trial: more than a small victory over sleeping sickness (English)

1 reference

7 September 2017

African trypanosomiasis

0 references

author name string

Jimmy Opigo

series ordinal

1

1 reference

PubMed ID

19559477

7 September 2017

Charles Woodrow

series ordinal

2

1 reference

PubMed ID

19559477

7 September 2017

language of work or name

English

0 references

publication date

24 June 2009

1 reference

7 September 2017

1 reference

7 September 2017

374

1 reference

7 September 2017

9683

1 reference

7 September 2017

7-9

1 reference

High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961163-6

7 January 2021

10.1016/S0140-6736(09)61163-6

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

19559477